SCHEMBL7977040

SCHEMBL7977040

[NH]C(=O)NCc1ccccn1

nearest known ligand 0.73

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.73
NPC1 O15118 3/20 0.62
RAB9A P51151 3/20 0.62
POLB P06746 3/20 0.62
LMNA P02545 2/20 0.62
ALDH1A1 P00352 4/20 0.59
KDM4E B2RXH2 1/20 0.59
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
GAA P10253 1/20 0.59
HPGD P15428 4/20 0.59
HTT P42858 1/20 0.59
ALOX15 P16050 2/20 0.58
TDP1 Q9NUW8 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL357801 0.85 SMN1; SMN2 (0.73) SMN1; SMN2NPC1RAB9APOLBLMNA
SCHEMBL18415475 0.85 SMN1; SMN2 (1.00) SMN1; SMN2NPC1RAB9APOLBLMNA
SCHEMBL21065524 0.85 SMN1; SMN2 (0.79) SMN1; SMN2NPC1RAB9APOLBALDH1A1
SCHEMBL30522589 0.85 SMN1; SMN2 (1.00) SMN1; SMN2NPC1RAB9APOLBLMNA
SCHEMBL29460273 0.85 SMN1; SMN2 (0.79) SMN1; SMN2NPC1RAB9APOLBALDH1A1
Hydrochloric Acid SCHEMBL27694741 0.84 SMN1; SMN2 (0.71) SMN1; SMN2NPC1RAB9APOLBLMNA
SCHEMBL10402199 0.83 SMN1; SMN2 (0.76) SMN1; SMN2NPC1RAB9APOLBLMNA
SCHEMBL243740 0.83 SMN1; SMN2 (0.76) SMN1; SMN2NPC1RAB9APOLBLMNA
SCHEMBL30602600 0.83 SMN1; SMN2 (0.76) SMN1; SMN2NPC1RAB9APOLBLMNA
SCHEMBL7979851 0.82 RAB9A (0.57) SMN1; SMN2NPC1RAB9ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001007409-A1 CARBAZOLE DERIVATIVES AND THEIR USE AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS ASTRAZENECA UK LIMITED (GB) 2001-02-01 WO disclosed